Clinical Fellow
National Institutes of Health
Disclosure(s): No financial relationships to disclose
Camellia Banerjee, M.D, Ph.D., is a Clinical Fellow in Infectious Disease in the Laboratory of Infectious Disease at National Institute of Allergy and Infectious Disease at the National Institutes of Health (NIH). Her clinical interests are primarily in infectious diseases in the context of intensive care settings, especially in immunocompromised populations. She obtained her M.D. and Ph.D. from Boston University School of Medicine. As part of her long standing interest in infectious disease, she took a sabbatical to study malaria in pregnancy in India during medical school. Her Ph.D. research was conducted with Dr. Monty Montano where she explored the interplay between muscle loss and accelerated aging in the context of HIV.
After completing her M.D./Ph.D., Dr. Banerjee completed two years of surgical residency at Montefiore Medical Center in the Bronx, NY before realizing her true passion was Infectious Disease. She subsequently completed a post-doctoral fellowship at the Albert Einstein School of Medicine with Dr. Liise-Anne Pirofski studying immunological host-responses to Prevnar 13 vaccination in HIV patients and aging populations. She then went on to complete a residency in Internal Medicine at North Shore University Hospital-Long Island Jewish Hospital at Hofstra School of Medicine, and a fellowship in Critical Care Medicine at Mt. Sinai Hospital in New York City before coming to the NIH for a Fellowship in Infectious Disease.
Dr. Banerjee is currently continuing her research activity at the NIH in the lab of Dr. Matthew Memoli studying influenza challenge models and pandemic potential vaccines with the goal of establishing independent research on respiratory viruses in critically ill in the future.